 ZUG, Switzerland and BOSTON, Oct. 05, 2022 GLOBE NEWSWIRE -- CRISPR Therapeutics Nasdaq: CRSP, a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced an oral presentation and a poster presentation at the Society for Immunotherapy of Cancer SITC 37th Annual Meeting, taking place in Boston, MA or virtually from November 8 to 12, 2022. 